Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

396
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
396

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortium.

medRxiv : the preprint server for health sciences·2026
Same author

Aberrant dynamic functional architecture in major depressive disorder: Vertex-Wise large-sample fMRI analyses reveal network-specific alterations and symptom associations.

Translational psychiatry·2026
Same author

Dynamic changes in hemispheric lateralization in major depressive disorder correlate with neurotransmitter and genetic profiles: a DIRECT consortium study.

Translational psychiatry·2025
Same author

Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics.

Communications medicine·2025
Same author

Towards closed-loop precision psychiatry: Integrating MRI biomarkers for individualized care of major depressive disorder.

Psychoradiology·2025
Same author

Characteristics of brain network connectome and connectome-based efficacy predictive model in bipolar depression.

Molecular psychiatry·2025

相关实验视频

Updated: May 20, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

927

基于MRI的可解释深度学习用于阿尔茨海默氏症风险和进展.

Bin Lu, Yan-Rong Chen, Rui-Xian Li

    medRxiv : the preprint server for health sciences
    |May 19, 2025
    PubMed
    概括

    这项研究表明,深度学习MRI模型可以准确地检测跨种族的阿尔茨海默病 (AD) 风险. 该工具可以提前几年预测进展情况,有助于对AD的早期干预.

    更多相关视频

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
    12:50

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

    Published on: April 14, 2014

    39.7K
    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
    09:06

    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

    Published on: June 9, 2018

    12.1K

    相关实验视频

    Last Updated: May 20, 2025

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    927
    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
    12:50

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

    Published on: April 14, 2014

    39.7K
    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
    09:06

    Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

    Published on: June 9, 2018

    12.1K

    科学领域:

    • 神经成像和人工智能的人工智能
    • 发现神经退行性疾病的生物标志物

    背景情况:

    • 早期发现阿尔茨海默病 (AD) 对于及时干预至关重要,尤其是在新兴免疫疗法方面.
    • 需要可访问和高效的生物标志物用于早期阿尔茨海默病诊断.

    研究的目的:

    • 评估先前开发的基于MRI的AD检测深度学习模型的跨民族概括性和临床实用性.
    • 评估模型预测未来AD进展和识别AD亚型的能力.

    主要方法:

    • 将使用北美数据开发的预训练深度学习模型应用于一个大型的中国队列 (SILCODE),其中包括722名参与者的1,105个脑MRI扫描.
    • 利用可解释的深度学习脑风险地图方法来识别AD亚型.
    • 与认知评估和血生物标志物 (陶蛋白,NfL) 相关联的模型衍生风险得分.

    主要成果:

    • 基于MRI的深度学习模型在不需要再培训的情况下显示出强大的跨民族概括性,达到91.3%的AUC和95.2%的AD分类灵敏度.
    • 该模型准确地确定了86.7%的个体在5年内面临阿尔茨海默病进展的风险,高风险个体呈现更快的进展.
    • 确定了不同的AD大脑亚型,包括与快速衰退相关的轻度认知障碍 (MCI) 亚型,风险得分与认知和血生物标志物显著相关.

    结论:

    • 基于MRI的深度学习模型在不同人群中表现出强大的概括性和临床实用性,用于早期AD检测和风险分层.
    • 该模型通过识别有风险的个体和亚型,为早期治疗干预提供了宝贵的工具.
    • 开源模型和免费的在线工具促进了阿尔茨海默病的广泛早期查和干预.